Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
97 Cards in this Set
- Front
- Back
what inhibits activated X?
|
1) LMWHeparin
2) fondaparinux |
|
what is HIT?
|
type 2:
heparin assoc. with platelet factor 4 protein--> IgG binds with this and forms immune complexes --> causes platelet degranulation and more PF4 release-->more IC's form=> THROMBOCYTOPENIA and THROMBOSIS |
|
Heparin (UFH) MOA?
|
stimulates ANTITHROMBIN III to work faster and inhibit thrombin
* doesn't inhibit thrombin thats already bound to fibrin =DTI's can do that |
|
how do you monitor heparin vs warfarin levels?
|
Heparin =PPT
Warfarin= PT |
|
what two drug classes work on thrombin?
|
Heparin- works thru ATIII to inhibit thrombin and therefore coagulation; no effect on fibrin bound thrombin
DTI's-(lepriudin,bivalirudin, argatroban) directly inhibit thrombin including fibrin-bound thrombin |
|
what do you treat HIT (heparin induced thrombocytopenia type II) with?
|
DTI ==> can inactivate fibrin bound thrombin (can break down already formed clots)
* i.e. lepirudin, bivalirudin, argatroban |
|
heparin vs warfarin
|
Heparin: parenteral;effective in seconds; doesn't cross placenta; , use PTT to moniter patients; both PT and PTT increased; antagonist is protamine sulfate; LMWH inhibts Xa more than ATIII
Warfarin: Oral; effective 8-12 hours later; crosses placenta; monitor with PT (think PeT="war" dog); both PT and PTT increase; antagonist is Vit.K; narrow TI |
|
causes of B12 def?
|
pernicious anemia, partial-taotal gasterectomy; malabsorption or resection in distal ileum where B12 absorbed
|
|
causes of folate def.?
|
1) pregnancy
2) alcoholics 3) hemolytic anemia 4) liver dz 5) pts on dialysis 6) drugs (medical) |
|
drugs that cause folic acid def.
|
1) Methotrexate, Trimethoprim, Pyrimethamine (all inhibit dihydrofolate reductase)
2)long term phenytoin use (rarely causes anemia tho) |
|
ferrous sulfate..oral or parenteral?
|
Oral
1) ferrous sulfate 2) ferrous gluconate 3) ferrous fumarate Parenteral 1) iron dextram 2) sodium ferric gluconate complex 3) iron sucrose |
|
Hydroyurea is used to treat ?
|
1) Sickle Cell
2) CML 3) Polycythemia vera *increases Fetal Hb and inhibits DNA synthesis |
|
Filgrastim MoA?
|
G-CSF (stimulates PMN production)
|
|
Sargramostin MoA?
|
GM-CSF ( stimulates myeloid and megakaryocyte progenitors via JAK/STAT receptors)
|
|
IL-11...?
|
Megakaryocyte growth factor
|
|
Hydroxycobalamin...?
|
B12 --> cofactor for many rxns
-treats B12 megaloblastic anemia |
|
Adverse effects of
1) aluminum hydroxide 2) magnesium hydroxide 3) calcium carbonate |
1) AlOH -constipation
2)MgOH - diarrhea (Must Go) 3)CaCO3 - kidney stones |
|
which H2 blocker inhibits P450?
|
Cimetidine
AE-cimetidine binds and inhibits androgen receptors- causes gynecomastia and decreases sperm count (men) and galactorrhea (women) |
|
Omeprazole inhibits metabolism of which drugs?
|
1)Warfarin
2)Phenytoin 3)Diazepam 4)Cyclosporine |
|
name the Proton Pump Inhibitors
|
1)Omeprazole
2)Esomeprazole |
|
DOC for erosive gastritis, active duodenal ulcers, long term tx of ZE syndrome?
|
PPI
1)esomeproazole 2)omeprazole |
|
H2 antagonist MoA?
|
Competitive and Reversibly blocks the H2 receptor
*histamine receptor on parietal cells of stomach; blocks 90% of acid production with single dose |
|
name cytoprotective drugs?
|
1) Sucralfate
2) Bismuth Subsalicylate 3) Misoprostol (PGE1 analog) *all stimulate prostaglandin, mucus and bicarb secretion |
|
what is contraindicated for cytoprotective agents?
|
-don't take antacids or H2 antagonists b/c cytoprotective agents like bismuth subsalicylate (pepto-bismol) and sucralfate need a low (ACIDIC) pH to become activated
|
|
where are PPI absorbed?
|
- pill has an acid-resistant coat that is removed in alkaline duodenum- pro-drug is absorbed and transported into parietal cell canaliculi --> conversion to active drug
* any enteric coated tablet shouldn't be taken with antacids- coat dissolves too early causing irritation- H2 and PPI) |
|
GPII/III receptor antagonists?
|
1)Abciximab
2)Eptifibatide 3)Tirofiban |
|
Tirofiban MoA?
|
-blocks GPII/III receptor on platelets
*receptor normally bind fibronectin, fribrinogen, vitronectin and vWF=>for platelet aggregation |
|
Eptifibatide?
|
GP II/III recpetor antagonist (blocks platelet aggregation)
|
|
name ADP receptor blockers?
|
1)Clopidogrel
2)Ticlopidine |
|
PDE Inhibitor in platelets?
|
1)Dipyridamole
|
|
Dipyridamole and Warfarin are used together in what condition/situation?
|
Prophylaxis of thromboemboli in pts with prothetic heart valves
*vaso-dilation and prevention of clot formation respectively |
|
NSAID induced gastric ulcer tx?
|
1) PPI's
2)H2 blockers 3)misoprostol |
|
PGE1 analog?
|
Misoprostol--> PGE inhibits secretion of HCL and stimulates mucus and bicarb secretion
|
|
what medication that is given for NSAID ulcers is C/I for pregnant patients?
|
Misoprostol
* causes uterine contractions; often used as an abortive medication |
|
what is used to maintain PDA?
|
Prostaglandins!
-misoprostol (PGE analog) |
|
name muscarinic agonists used to suppress acid secretion?
|
1) pirenzepine
2) dicyclomine *dont confuse dicyclomine with dipyridamole (PDE inhibitor-vasodilator) |
|
irreversible inhibitors of P2Y 12?
|
ADP receptors (PY2 12) are blocked by
1)Clopidogrel 2)Ticlopidine |
|
when do you use muscarinic antagonists to prevent acid secretion?
|
pirenzipine -peptic ulcers in refractory cases
dicyclomine- used in IBS |
|
H.Pylori regimens?
|
1) PPI + clarithromycin+amoxicillan
2)PPI + clarithromycin+metronidazole 3)PPI/Ranitidine + Bismuth+ metronidazole+ tetracycline * all 10-14 day course |
|
Name the Prokinectic drugs...
|
1) Metoclopramide
2) Cisapride |
|
Metoclopramide MoA?
|
D2 receptor antagonist; also mixed 5HT3 antag/5HT4 agonist
*speeds up GI -used for diabetic gastroparesis; anti-emetic; GERD -can cause inc. parkinsonian effects; -C/I in pts with SI obstruction |
|
Cisapride ?
|
-release Ach in myenteric plexus to increase muscle tone in esophageal sphincter
*used for diabetic gastroparesis (inc. gastric emptying); GERD; bowel constipation AE: long QT syndrome ->arrthymias with ketoconazole or erythromycin; diarrhea |
|
name a D2 antagonist that work in the GI?
|
1)Metoclopramide
|
|
Name a drug that increases release of ACH in the myenteric plexus of GI
|
1) Cisapride
|
|
Which GI muscarinic antagonist has poor CNS penetration?
|
Pirenzepine
*muscarinics work through the M receptors on the parietal cell |
|
What is the difference between pirenzipine and cisapride?
|
pirenzipine - muscarinic antagonist; used for refractory ulcers
cisapride - prokinectic drug that releases Ach in myenteric plexus |
|
what drugs are given to increase gastric emptying in diabetics?
|
1) Metoclopramide
2) Cisapride |
|
1) which drug has long QT syndrome?
2) which added drugs predispose these pt to arrthymias? |
1)Cisapride
2) Cisapride with erythromycin or ketoconazole *erthyro and keto are p450 inhibitors |
|
what treats opiod induced constipation?
|
senna (with docusate)
* stimulant |
|
which laxative is an irritant?
|
castor oil-->rincinoleic acid-->increases peristalsis
*C/I in pregnant pts |
|
lactulose,PEG, Mg citrate?
|
osmotic laxatives
PEG- polyethylene gycol is used as coloni lavage for endoscopy/rediological procedures |
|
CHRONIC INGESTION OF THIS ANTACID WITH MILK CAN INDUCE MILK-ALKALI SYNDROME
|
CALCIUM CARBONATE
(can result in hypercalcemic alkalosis with development of renal calculi) |
|
USED IN THE TX OF GERD, THIS HISTAMINE BLOCKER IN ASSOCIATED WITH GYNECOMASTIA AND GALACTORRHEA
|
CIMETIDINE
(the stronger blockers, ranitidine and famotidine, don't inhibit P450 system and therefore dont cause anti-androgenic effects) |
|
mechanism of vomiting
|
1) CTZ of area postrema->outside BBB so can respond to chemicals in blood/CSF
2)vomiting center in medulla-->coordinates motor mechanism of vomiting-->responds from afferent imput from vestibular system,GI, pharynx |
|
HI antagonists..?
|
1)dimenhydrinate
2)meclizine 3)cyclizine |
|
Procholoroperazine MoA?
|
class of drug: phenothiazines
- D2 blocker (also metoclopramide) |
|
Emetic Neurotransmitters..?
|
1)dopamine -->D2 receptors
2) Serotonin --> 5HT3 3)Vagal --> Ach 4)Neurokinin/Sub P in CNS |
|
what do metoclopromide and prochorperazine have in common?
|
both are D2 blockers
*metoclopromide--> effective against cisplastin which is highly emetogenic; also GERD,Diabetic gastroparesis prochloroperazine--> used for low/moderate CHEMO vomiting |
|
Tx of motion sickness?
|
1)scopolamine
2)dimenhydrinate 3)meclizine 4)cyclizine |
|
Chemotherapy anti emetics?
|
1)5HT3 blockers (Ondansetron, Granisetron, Dolasetron)
2)Phenothiazines (Procholorperazine) 3)Corticosteroids (Dexamethasone, Methyl-prednisolone) 4)Marijuana derivative (Dronabinol, Nabilone) |
|
butyrophenones?
|
1)Droperidol (prolongs QT)
2)Haloperidol *block D2 receptors; for refractory cases |
|
benzodiazepines?
|
1)Lorazepam
2)Alprazolam (anticipatory vomiting-->low potency) |
|
what blocks Neurokinin/ substance P?
|
Aprepitant
(usu administered with dexamethasone and palonsetron; extensive CYP3A4 metabolism;can induce it too) |
|
COMMONLY USED ANALGESIC AND ANTI-PYRETIC BUT UNLIKE NSAIDS, HAS NO ANTI-INFLAMMATORY PROPERTIES
|
ACETAMINOPHEN
(weak inhibitor of COX, it inhibits prstaglandin synthesis in the CNS; a related rpo-drug PHENACITIN, is no longer avaiable due to nephrotoxicity) |
|
USED INT EH MANAGEMENT OF CHRONIC GOUT AND AS AN ADJUNCT TO CANER CHEMO, TO SLOW THE PRODUCTION OF URIC ACID
|
ALLOPURINOL
(results in suicide inhibition of xanthine oxidase with resultant increase of xanthine and hypoxanthine, both of whihc are more soluable and less likely to for m crystals than uric acid) |
|
NSAID WITH ANTI-PYRECTIC, ANALGESIC, ANTI-PLATELET, AND ANTI-INFLAMMATORY PROPERTIES THAT IRREVERSIBLY INHIBIT COX
|
ASPRIN
(inhibits the formation of PGE, decreases paina nd fever, and decreases snthesis of PGE in stomach, predisposing to acute gastritis) |
|
USED TOPICALLY FOR THE TREATMENT RHEUMATOID ARTHRITIS BECAUSE IT DEPLETES SUBSTANCE P
|
CAPSAICIN
(component of chili peppers that impairs release of sub P, the potent neurotranmitter for pain sensation) |
|
NEWLY AVAILABLE NSAID, USED IN THE TX OF RHEUMATOID ARTHRITIS AND OTHER CHRONIC CONDITIOS, WITH A DECREASED RISH OF ULCERS AND OTHER GI BLEEDS
|
CELECOXIB
(celecoxib and a similar drug, rofecoxib, selectively inhibit cox-2 present only in leukocytes; these agents don't inhibit cox-1 that produces protective prostaglandins int eh stomach; as sulfa drugs they can both cause hypersenitivy reactions) |
|
USED FOR TX OF ACUTE ATTACKS OF GOUTY ARTHRITIS, BECAUSE IT IMPAIRS LEUKOCYTE FUNCTION
|
CHOLCHICINE
(inhibits microtuble assembly, and therefore leukocyte migration and phagocytosis of uric acid crytals) |
|
USED IN THE TX OF TRANSPLANT PATIENTS AND PATIENTS WITH AUTOIMMUNE DZ'S, AS IT IMPAIRS T CELL PRODUCTION OF IL-2
|
CYCLOSPORINE
(binds to cyclophilins and inhibits the tanscription of cytokine genes; a similar agent, tacrolimus, binds to the immunophilin FK-binding protein (FKBP) and functions similarly;both display a dose-limiting nephrotoxicity) |
|
A BACTERIAL PRODUCT OF STREP PYOGENES, USED IN THE TX OF CORONARY ARTERY THROMBOSIS
|
STREPTOKINASE
(complexes with and catalyzes the conversion of plasminogen to plasmin; it is cheaper, although debatably equivalent, agent to tPA) |
|
PLATELET ANTI-AGGREGANT, USED FOR THE PREVENTION OF TRANSIENT ISCHEMIC ATTACKS IN PATIENTS WITH ASPRIN SENSITIVITY
|
TICLOPIDINE
(interferes with the binding of fibrin to the GPIIa/IIIb receptor blocker (class notes=> ADP blocker)) |
|
CREATED THROUGH THE USE OF RECOMBINANT DNA TECHNOLOGY, THIS AGENT IS USED FOR CORONARY ARTERY THROMBOSIS AND ISCHEMIC STROKE
|
TISSUE PLASMIOGEN ACTIVATOR (tPA) ALTEPLASE/RETEPLASE
(converts fibrin bound plasminogen to plasmin resulting in the dissolution of thrombi) |
|
ORALLY ADMINISTERED ANTICOAGULANT USED IN THE MANAGEMENT AND PROPHYLAXIS OF VENOUS THROMBOSIS, MI AND STROKE
|
WARFARIN
(coumadin compound that interferes with the vit.k dependent carboxylation of clotting factors 2,7,9,10) |
|
MONOCLONAL ANTIBODY USED AS AN ANTICOAGULANT, PREVENTING RE-STENOSIS AFTER CORONARY ANGIOPLASTY
|
ABCIXIMAB
(antibodies against the GPII/III receptor on platelets, preventing platelet aggregation) |
|
USED IN THE TREATMENT OF ACUTE BLEEDING IN PATIENTS WITH HEMOPHILIA AND OTHER COAGULAPATHIES
|
AMINOCAPROIC ACID
(orally active inhibitor of plasminogen activation, thereby inhibiting fibrinolysis, tranexamic acid is a similar agent) |
|
RECOMBINANT PRODUCT USED IN THE TX OF ANEMIA ASSOCIATED WITH RENAL FAILURE
|
ERYTHROPOIETIN (DARBOPOIETIN/EPOETIN ALPHA)
( also used to tx anemia assoc with bone marrow transplants or toxic drug reactions) |
|
WILL CORRECT THE ANEMIA BUT NOT THE NEUROLOGICAL DEFICITS ASUED BY VIT B12 DEF.
|
FOLIC ACID
|
|
RAPID ACTING IV ADMINISTERED ANTI-COAGULANT USED FOR ACUTE MYOCARDIAL INFARCTION AND PREVENTION OF DVT FOLLOWING PROLONGED IMMOBILIZATION
|
HEPARIN
(bind to and activate ATIII, resulting in inactivation of thrombin and other clotting factors) |
|
USED IN THE MANAGEMENT OF SICKLE CELL ANEMIA AS WELL AS FOR VARIOUS MYELOID NEOPLASMS
|
HYDROXYUREA
(increases HbF and als inhibits DNA synthesis by blocking conversion of ribonucleotides to deoxyribinucleotides) |
|
RECOMBINANTLY PRODUCED GRANULOCYTE-MACROPHAGE COLONYSTIMULATIONG FACTOR, USED IN THE MANAGEMENT OF PATIENTS UNDERGOING CHEMO
|
SARGRAMOSTIM
(similar agent G-CSF filgrastim is used for similar applications but affects on granulocytes) |
|
PROKINETIC DRUF USED TO TX UPPER GI DYSFUNCTION SUCH AS GERD OR GASTROPARESIS WITH DELAYED GASTRIC EMPTYING
|
CISAPRIDE (aka Propulsid)
(stimulates peristalsis by promoting the release of Ach from post-ganglionic nerves of the myenteric plexus, high does have been assoc with long QT syndrome) |
|
OPIOD DERIVATIVE USED IN TX OF DIARRHEA, B/C THEY SUPPRESS GI MOTILITY
|
DIPHENOXYLATE, LOPERIMIDE
whereas diphenoxylate is formulated with anti-muscarinic alkaloids; both preparations have minimal abuse potential) |
|
THIS PREPARATION IS USED TO TREAT EMESIS AND NAUSEA ASSOC, WITH CHEMO, AND CONTAINS THE ACTIVE INGREDIENT IN MARIJUANA
|
DRONABINOL
|
|
commonly used pro-emetic agent used in cases of ingestion of caustic substances or mineral oils
|
ipecac syrup
(orally administered drug that acts directly on the chemoreceptor trigger zone (CTZ) in the medulla) |
|
AMONG THE MOST POPULAR ANTACIDS USED IN THE U.S. NEITHER ABSORBED AND THEREFORE CAUSES NO SYSTEMIC EFFECTS
|
MG OH or AL OH
(MgOH has a strong laxative effect, AlOH causes constipation |
|
THIS PRO-KINECTIC AGENT IS USED TO PREVENT EMESIS ( I.E. POST-ANESTHESIA OR D/T CHEMO), BECAUSE IT BLOCKS D2 RECEPTORS INT HE AREA POSTREMA THAT TRIGGER VOMITING
|
METOCLOPRAMIDE
(facilitates Ach, while antagonizing the action of dopamine on teh enteric nervous system. side effects include sedation, diarrhea, and extrapyramidal symptoms) |
|
EICOSANOID PREPARATION USED TO PREVENT PEPTIC ULCERS IN PATIENTS TAKING HIGHER DOSES OF NSAIDS FOR CONDITIONS SUCH AS RHEUMATOID ARTHRITIS
|
MISOPROSTOL
(PGE analog decreases gastric acid production and increases mucus production, protecting the lining of the stomach) |
|
PPI USED IN THE TX OF GERD, GASTRIC AND DUODENAL ULCERS, H.PYLORI GASTRITIS, AND ZE SYNDROME
|
OMEPRAZOLE
(irreversibly inhibits the H+/K+ ATPase on the luminal side of the parietal cells) |
|
CENTRAL ACTING ANTI-EMETIC USED TO CONTROL POST-OPERATIVE VOMITING in CHEMO PATIENTS
|
ONDANSETRON
(5HT3 inhibitor that function at the chemorecoetive area of the area postrema) |
|
USED TO TX PEPTIC ULCERS, BECAUSE IT POLYMERIZES AND SELECTIVELY COATS NECROTIC ULCERATED TISSUE
|
SUCRALFATE
(requires and acidic envoronment to polymerize, and therefore, can't be used in the presence of antaacids or H2 blockers |
|
USED FOR THE TX OF TRAVELER'S DIARRHEA
|
BISMUTH SUBSALICYLATE
(helps decrease fluid secretion by the bowel, also used with metronidazole and tetracycline for the tx of H.pylori associated PUD |
|
INHIBITS THE RATE-LIMITING ENZYME OF CHOLESTEROL SYNTHESIS, HMG-CoA REDUCATASE, RESULTING IN DRAMATICALLY DECREASED LDL LEVELS
|
STATINS (LOVASTATIN,PRAVASTATIN/SIMVASTATIN/ATORVASTATIN)
(may cause elevated liver enzymes, myositis with increased creatine kinase from skeletal muscle and rarely rhabdomyolysis) |
|
ANTI-HYPERLIPIDIDEMIC AGENT THAT MAY PREVENT ATHEROSCLEROSIS BY ACTING AS AN ANTIOXIDANT
|
PROBUCOL
(rarely used for tx of hyperlipidemia because it decreases HDL's as well as LDLs;may be efficacious in preventing restenosis after angioplasty |
|
LIPID LOWERING AGENT CAUSES CUTANEOUS FLUSHING, WHICH CAN BE AVOIDED BY ADMINISTERING CONCURRENTLY WITH ASPIRIN
|
NIACIN
(directly reduces secretion of VLDL's from and apoliprotein synthesis by the liver, while increasing HDL's) |
|
AGENTS THAT DECREASE TRIGLYCERIDES DRAMATICALLY BY STIMULATING LIPOPROTEIN LIPASE
|
GEMFIBROZIL,FENOFIBRATE, CLOFIBRATE
(clofibrate has been associated with gallstones and hepatobiliary neoplasms) |
|
BILE ACID-BINDING RESINS USED IN THE MANAGEMENT OF HYPERLIPIDEMIA
|
CHOLESTYRAMINE, COLESTIPOL
(bind bile acids, preventing enterohepatic recycling, thus diverting hepatic efforts to renew bile acids, instead of producing plasma lipids) |